Clincosm LogoSign in Get a demo

Colon Cancer

Showing NaN - NaN of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Advanced Malignant Solid Tumor, RAS Mutation, Lung Cancer Trial in United States (RSC-1255 Dose Escalation, RSC-1255 Dose

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +5 more
  • RSC-1255 Dose Escalation
  • RSC-1255 Dose Expansion
  • Los Angeles, California
  • +5 more
Oct 24, 2022

NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Scottsdale, Arizona
  • +84 more
Oct 10, 2022

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

Available
  • Non Small Cell Lung Cancer
  • +6 more
  • Goodyear, Arizona
  • +67 more
Aug 17, 2022

Cancer, Breast Cancer, Colon Cancer Trial in Los Angeles (Change in knowledge, motivation, skills, and resources)

Withdrawn
  • Cancer
  • +4 more
  • Change in knowledge, motivation, skills, and resources
  • Los Angeles, California
    Charles R. Drew University of Medicine & Science
Jul 22, 2022

Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,

Active, not recruiting
  • Breast Cancer
  • +10 more
  • Los Angeles, California
  • +7 more
Jun 21, 2022

Prevention of Colorectal Cancer Through Multiomics Blood Testing

Recruiting
  • Colon Cancer
  • +10 more
  • Freenome test
  • Anniston, Alabama
  • +173 more
Mar 9, 2022

Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

Terminated
  • Mesothelioma
  • +12 more
  • MGD009
  • Los Angeles, California
  • +19 more
Feb 4, 2022

Rectal Cancer, Colon Cancer, Crohn's Disease Trial in United States (PINPOINT Endoscopic Fluorescence Imaging System)

Completed
Has Results
  • Rectal Cancer
  • +5 more
  • PINPOINT Endoscopic Fluorescence Imaging System
  • Los Angeles, California
  • +10 more
Nov 19, 2018

Anxiety Disorder, Colon Cancer, Depression Trial in Los Angeles (educational intervention, CAM exercise therapy,

Terminated
  • Anxiety Disorder
  • +4 more
  • educational intervention
  • +4 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Nov 27, 2017

Colon Cancer, Colorectal Cancer Trial in Los Angeles (EPO906, celecoxib)

Unknown status
  • Colon Cancer
  • Colorectal Cancer
  • EPO906, celecoxib
  • Los Angeles, California
    U.S.C./Norris Comprehensive Cancer Center
Jun 23, 2017

Colon Cancer, Rectal Cancer Trial in Los Angeles (Educational program and FOBT kits, Educational program and FOBT kits, and

Completed
  • Colon Cancer
  • Rectal Cancer
  • Educational program and FOBT kits
  • Educational program and FOBT kits, and technical assistance
  • Los Angeles, California
    UCLA Division of Cancer and Prevention Research
Jul 28, 2016

Novel Biophotonics Methodology for Colon Cancer Screening

Completed
  • Colon Cancer
    • Los Angeles, California
    • +4 more
    Jun 9, 2016

    Colon Cancer, Colonoscopy Trial in Los Angeles (Receiving an educational booklet)

    Completed
    • Colon Cancer
    • Colonoscopy
    • Receiving an educational booklet
    • Los Angeles, California
      West Los Angeles VA Healthcare Center
    Dec 9, 2014

    Colorectal Cancer, Colon Cancer Trial in Los Angeles (gemcitabine, capecitabine)

    Completed
    • Colorectal Cancer
    • Colon Cancer
    • gemcitabine, capecitabine
    • Los Angeles, California
      U.S.C./Norris Comprehensive Cancer Center
    May 20, 2014

    Colon Cancer, Colorectal Cancer Trial in Los Angeles (capecitabine, imatinib mesylate)

    Completed
    • Colon Cancer
    • Colorectal Cancer
    • capecitabine, imatinib mesylate
    • Los Angeles, California
      USC/Norris Cancer Center
    May 20, 2014

    Colon Cancer Trial in Los Angeles (recombinant nematode anticoagulant protein c2 (rNAPc2))

    Suspended
    • Colon Cancer
    • recombinant nematode anticoagulant protein c2 (rNAPc2)
    • Los Angeles, California
      LAC/USC Medical Center
    May 5, 2008